Readjustable midurethral sling (REMEEX system) in obese women
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Woong Bin | - |
dc.contributor.author | Lee, Sang Wook | - |
dc.contributor.author | Lee, Kwang Woo | - |
dc.contributor.author | Kim, Jun Mo | - |
dc.contributor.author | Kim, Young Ho | - |
dc.contributor.author | Kim, Min Eui | - |
dc.date.accessioned | 2021-08-11T09:23:48Z | - |
dc.date.available | 2021-08-11T09:23:48Z | - |
dc.date.issued | 2019-11 | - |
dc.identifier.issn | 2466-0493 | - |
dc.identifier.issn | 2466-054X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/4122 | - |
dc.description.abstract | Purpose: To evaluate the success rate and patient satisfaction with the readjustable midurethral sling (REMEEX system) for the treatment of stress urinary incontinence (SUI) with intrinsic sphincter deficiency (ISD) or recurrent SUI in obese and non-obese women. Materials and Methods: Between August 2009 and August 2015, 70 patients who treated with the REMEEX system were stratified into normal, overweight and obesity groups according to body mass index. Objective surgical outcomes were evaluated using a 1-hour pad test that was performed 3 months after surgery. The subjective outcomes and degree of patient satisfaction were evaluated 3 months and 1 year after surgery. Results: Twenty-six normal weight, 31 overweight, and 13 obese women were included in the study. The objective cure rate determined using the 1-hour pad test revealed that 11 women (42.3%) were cured and 15 (57.7%) had improved in the normal weight group, respectively, compared with 16 (51.6%) and 15 (48.4%) in the overweight group and 6 (46.2%) and 7 (53.8%) in the obese group, respectively (p=0.78). One year after surgery, the subjective success rate was 91.5% in the normal weight group, 93.5% in the overweight group and 92.3% in the obese group. A total of 84.7%, 77.4%, and 77.0% of normal weight, overweight and obese women were very satisfied or satisfied 1 year after surgery, respectively. All groups showed similar success rates and satisfaction. Conclusions: The REMEEX procedure is equally effective in obese and normal weight women with ISD-type SUI or recurrent SUI. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한비뇨기과학회 | - |
dc.title | Readjustable midurethral sling (REMEEX system) in obese women | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4111/icu.2019.60.6.488 | - |
dc.identifier.scopusid | 2-s2.0-85074587523 | - |
dc.identifier.wosid | 000493914400010 | - |
dc.identifier.bibliographicCitation | Investigative and Clinical Urology, v.60, no.6, pp 488 - 495 | - |
dc.citation.title | Investigative and Clinical Urology | - |
dc.citation.volume | 60 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 488 | - |
dc.citation.endPage | 495 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002521334 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | STRESS URINARY-INCONTINENCE | - |
dc.subject.keywordPlus | BODY-MASS INDEX | - |
dc.subject.keywordPlus | DEFICIENCY | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | TAPE | - |
dc.subject.keywordPlus | COMPLICATIONS | - |
dc.subject.keywordPlus | SURGERY | - |
dc.subject.keywordAuthor | Obesity | - |
dc.subject.keywordAuthor | Suburethral slings | - |
dc.subject.keywordAuthor | Urinary incontinence | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.